Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Nathan Hale, DO, MS

Advertisement

Articles by Nathan Hale, DO, MS

Balancing Family With Career Goals During an Oncology Fellowship

ByNathan Hale, DO, MS
November 1st 2017

Successfully attaining our goals in fellowship is demanding. They are accomplished by establishing work/life balance.

Advertisement

Latest Updated Articles

  • Balancing Family With Career Goals During an Oncology Fellowship
    Balancing Family With Career Goals During an Oncology Fellowship

    November 1st 2017



Advertisement
Advertisement

Trending on OncLive

1

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

2

CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma

3

FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma

4

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

5

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us